Fortune - Last week, the FDA approved a first-of-its-kind medical device to track whether patients are actually taking their medications. The device is a triumph of technology—it may represent an important tool to support team-based care for complex patients—but it forces us to consider a host of new questions about the limits of technology in health care delivery.
The approved device is a tiny chip embedded in Abilify, a medication used to treat schizophrenia. When swallowed, and once it makes contact with a patient’s stomach acid, the chip releases a signal that a patch—which the patient wears—retrieves...>>>
Nessun commento:
Posta un commento